Search Results for “”

This week: rescue dogs on the catwalk, dog mats go upscale, and the Flintstones got it wrong about Dino

The Food and Drug Administration (FDA) announced last Friday that they were ending a controversial experiment on nicotine addiction. The experiment involved having adolescent squirrel monkeys self-administer doses of nicotine until they were addicted so scientists could study the effects. The study began in 2014. By the summer of 2017, four of the test monkeys had died

This week: a Staffordshire terrier peers reviews papers, Colorado pays the tab for large animal vet students, and who gets the dog in a divorce?

AAHA and management consulting firm, The Coffman Organization (TCO), have announced a collaboration to study and build stronger, healthier workplaces within the veterinary profession. The mission-oriented and often emotionally taxing work conducted by veterinary healthcare providers presents unique challenges that can lead to difficult work environments and a multitude of mental health conditions.

Catch up on the latest pet and veterinary news from the last week. In this update: Reporting animal abuse becomes mandatory in parts of Canada, a cloned dog gets cloned, and yes, dogs are smarter than cats.

Ready to improve your practice’s diabetes management game? AAHA’s newly revised Diabetes Management Guidelines feature a robust resource center full of mobile-friendly tools and educational materials to empower practitioners and pet owners alike.

This week: checking for microchips becomes law in New York, why more dogs aren't sniffing out cancer, and nipping compassion fatigue in the bud

The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.